NOX4 and pancreatic neoplasm: In oncogenic RAS-driven human pancreatic tumors and in pancreatic cancer mouse models, the levels of the ROS-inducing NOX4 correlate positively with tumor progression, indicating a heightened reliance on ROS during tumorigenesis (Ogrunc et al., 2014).